title: Defining vitamin D status by secondary hyperparathyroidism in the U.S. population.
abstract: BACKGROUND
  Vitamin D is associated with a variety of health outcomes, but the exact definition of vitamin D sufficiency remains controversial.
  
  
  OBJECTIVE
  We sought to define skeletal-related vitamin D sufficiency by estimating maximum PTH suppression in the U.S. population.
  
  
  METHODS
  We performed a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES), 2003-2006. We examined the association between serum 25-hydroxyvitamin D (25OHD) level and serum PTH level in 14,681 participants aged ≥6 yr. We also evaluated the 25OHD-PTH association using 2 thresholds of hyperparathyroidism: PTH≥45 pg/ml and ≥75 pg/ml.
  
  
  RESULTS
  The mean 25OHD level was 24 ng/ml and mean PTH was 42 pg/ml. PTH≥45 pg/ml was present in 35% of the population, while PTH≥75 pg/ml was present in 7%. The prevalence of 25OHD levels <40 ng/ml and <30 ng/ml was 95% and 77%, respectively. In both unadjusted and adjusted models, there was a strong inverse relationship between 25OHD and PTH. Compared to 25OHD≥40 ng/ml, the 25OHD-PTH association was 2.36 [95% confidence interval (CI), 2.08-2.67] times greater for 25OHD<5 ng/ml and 1.12 (95%CI, 1.07-1.17) times greater for 25OHD 30-39.9 ng/ml. Compared to 25OHD≥40 ng/ml, 25OHD levels of 20- 29.9 ng/ml [odds ratio (OR) 2.0 (95%CI, 1.4-2.8)] but not 30- 39.9 ng/ml [OR 1.1 (95%CI, 0.8-1.6)] were independently associated with PTH≥45 pg/ml.
  
  
  CONCLUSIONS
  Optimal vitamin D status, defined by estimated maximum PTH suppression, does not occur until at least 25OHD levels ≥40 ng/ml. Using these thresholds, most of the U.S. population needs more vitamin D. Large, prospective studies are needed to determine optimal vitamin D supplementation.
authors: Department of Emergency Medicine, University of Colorado Denver School of Medicine, Aurora, CO 80045, USA. adit.ginde@ucdenver.edu
authors: A A
authors: AA
authors: Ginde
authors: P
authors: P
authors: Wolfe
authors: C A
authors: CA
authors: Camargo
authors: R S
authors: RS
authors: Schwartz
references: Am J Clin Nutr. 2006 Sep;84(3):602-9
references: 16960175
references: Am J Clin Nutr. 2007 Jun;85(6):1586-91
references: 17556697
references: J Hypertens. 2008 Jul;26(7):1390-4
references: 18551015
references: Eur J Cardiovasc Prev Rehabil. 2004 Feb;11(1):69-74
references: 15167209
references: Cochrane Database Syst Rev. 2009 Apr 15;(2):CD000227
references: 19370554
references: JAMA. 1995 Dec 6;274(21):1683-6
references: 7474272
references: Eur J Cancer Prev. 2009 Nov;18(6):458-75
references: 19730382
references: Am J Clin Nutr. 1998 Feb;67(2):342-8
references: 9459385
references: J Intern Med. 2007 Jun;261(6):558-65
references: 17547711
references: J Hypertens. 2005 Sep;23(9):1639-44
references: 16093907
references: Kidney Int Suppl. 2003 Jun;(85):S44-8
references: 12753264
references: Am J Clin Nutr. 2006 Jul;84(1):18-28
references: 16825677
references: J Am Coll Nutr. 2003 Apr;22(2):142-6
references: 12672710
references: Osteoporos Int. 1997;7(5):439-43
references: 9425501
references: Lancet. 1974 Feb 16;1(7851):229-33
references: 4130245
references: Endocr Pract. 2006 Mar-Apr;12(2):137-44
references: 16690460
references: Arch Intern Med. 2008 Jun 9;168(11):1174-80
references: 18541825
references: JAMA. 2005 Nov 9;294(18):2336-41
references: 16278362
references: Paediatr Child Health. 2007 Sep;12(7):583-98
references: 19030432
references: Pediatrics. 1976 Feb;57(2):221-5
references: 175345
references: Arch Intern Med. 2009 Feb 23;169(4):384-90
references: 19237723
references: Am J Clin Nutr. 2009 Sep;90(3):695
references: 19571227
references: J Clin Endocrinol Metab. 2001 Jul;86(7):3086-90
references: 11443171
references: N Engl J Med. 2007 Jul 19;357(3):266-81
references: 17634462
references: N Engl J Med. 1998 Mar 19;338(12):777-83
references: 9504937
references: Arch Intern Med. 2009 Mar 23;169(6):626-32
references: 19307527
references: Arch Intern Med. 2008 Jun 23;168(12):1340-9
references: 18574092
references: J Bone Miner Res. 1998 Mar;13(3):475-82
references: 9525348
references: J Clin Endocrinol Metab. 2000 Nov;85(11):4125-30
references: 11095443
references: Am J Clin Nutr. 2001 Aug;74(2):206-10
references: 11470722
references: Am J Public Health. 2006 Feb;96(2):252-61
references: 16380576
references: Epidemiol Infect. 2006 Dec;134(6):1129-40
references: 16959053
references: J Clin Endocrinol Metab. 2003 Jan;88(1):185-91
references: 12519850
references: J Am Geriatr Soc. 2009 Sep;57(9):1595-603
references: 19549021
references: J Clin Endocrinol Metab. 2004 Apr;89(4):1646-9
references: 15070925
references: J Bone Miner Res. 2000 Sep;15(9):1856-62
references: 10977006
references: Am J Clin Nutr. 1997 Mar;65(3):790-7
references: 9062531
references: J Clin Endocrinol Metab. 2009 Apr;94(4):1244-50
references: 19158198
references: Science. 2006 Mar 24;311(5768):1770-3
references: 16497887
references: Am J Clin Nutr. 1997 Jan;65(1):67-71
references: 8988915
references: Circulation. 2008 Jan 29;117(4):503-11
references: 18180395
references: Osteoporos Int. 2005 Jan;16(1):109-13
references: 15175848
references: Endocr Rev. 2001 Aug;22(4):477-501
references: 11493580
references: Am J Clin Nutr. 2007 Mar;85(3):649-50
references: 17344484